Glutamate receptors - Prenatal insults, long-term consequences

Pharmacology Biochemistry and Behavior

Volumn 100, Issue 4, 2012, Pages 835-840

  Griesmaier, Elke ^a   Keller, Matthias ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

AMPA; Fetal; Glutamate; NMDA; Pregnancy; Receptor

Indexed keywords

ALCOHOL; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; COCAINE; DEXTROMETHORPHAN; DIZOCILPINE; KAINIC ACID RECEPTOR; MAGNESIUM SULFATE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID; TOPIRAMATE; XENON;

ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; APOPTOSIS; BRAIN DEVELOPMENT; BRAIN INJURY; BRAIN ISCHEMIA; CELL DEATH; COGNITION; ENVIRONMENTAL FACTOR; EXCITOTOXICITY; HUMAN; HYPERGLYCINEMIA; LOCOMOTION; NONHUMAN; PATHOPHYSIOLOGY; PERINATAL PERIOD; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; REVIEW; SENSORIMOTOR FUNCTION; SIDE EFFECT; STRESS;

BRAIN; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; RECEPTORS, GLUTAMATE; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 84855519834     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.04.011     Document Type: Review

References (95)

1. Alcohol use among pregnant, nonpregnant women of childbearing age - United States. MMWR Morb.Mortal.Wkly.Rep. 1991-2005;58(529-532):2009.
2. Adde-Michel C, Hennebert O, Laudenbach V, Marret S, Leroux P. Effect of perinatal alcohol exposure on ibotenic acid-induced excitotoxic cortical lesions in newborn hamsters. Pediatr Res 2005;57:287-93. (Pubitemid 40165610)
3. Akaike A, Tamura Y, Terada K, Nakata N. Regulation by neuroprotective factors of NMDA receptor mediated nitric oxide synthesis in the brain and retina. Prog Brain Res 1994;103:391-403.
4. Alberdi E, Sanchez-Gomez MV, Torre I, Domercq M, Perez-Samartin A, Perez-Cerda F, et al. Activation of kainate receptors sensitizes oligodendrocytes to complement attack. J Neurosci 2006;26:3220-8.
5. Almeida RD, Manadas BJ, Melo CV, Gomes JR, Mendes CS, Graos MM, et al. Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ 2005;12:1329-43. (Pubitemid 41486103)
6. Anand KJ. Effects of perinatal pain and stress. Prog Brain Res 2000;122:117-29. (Pubitemid 30114473)
7. Andersen JD, Pouzet B. Spatial memory deficits induced by perinatal treatment of rats with PCP and reversal effect of D-serine. Neuropsychopharmacology 2004;29:1080-90. (Pubitemid 38670046)
8. Back SA, Gan X, Li Y, Rosenberg PA, Volpe JJ. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci 1998;18:6241-53. (Pubitemid 28373231)
9. Bakshi K, Gennaro S, Chan CY, Kosciuk M, Liu J, Stucky A, et al. Prenatal cocaine reduces AMPA receptor synaptic expression through hyperphosphorylation of the synaptic anchoring protein GRIP. J Neurosci 2009;29:6308-19.
10. Benke D, Wenzel A, Scheuer L, Fritschy JM, Mohler H. Immunobiochemical characterization of the NMDA-receptor subunit NR1 in the developing and adult rat brain. J Recept Signal Transduct Res 1995;15:393-411.
11. Bhuvaneswar CG, Chang G, Epstein LA, Stern TA. Alcohol use during pregnancy: prevalence and impact. Prim. Care Companion. J. Clin. Psychiatry 2007;9:455-60. (Pubitemid 350278285)
12. Bolser DC. Current and future centrally acting antitussives. Respir Physiol Neurobiol 2006;152:349-55. (Pubitemid 44037507)
13. Bueter W, Dammann O, Leviton A. Endoplasmic reticulum stress, inflammation, and perinatal brain damage. Pediatr Res 2009;66:487-94.
14. Carpenter CL, Marks SS, Watson DL, Greenberg DA. Dextromethorphan and dextrorphan as calcium channel antagonists. Brain Res 1988;439:372-5. (Pubitemid 18065726)
15. Chandler LJ, Newsom H, Sumners C, Crews F. Chronic ethanol exposure potentiates NMDA excitotoxicity in cerebral cortical neurons. J Neurochem 1993;60:1578-81. (Pubitemid 23088340)
16. Chen HS, Wang YF, Rayudu PV, Edgecomb P, Neill JC, Segal MM, et al. Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation. Neuroscience 1998;86:1121-32. (Pubitemid 28318538)
17. Chien YH, Hsu CC, Huang A, Chou SP, Lu FL, Lee WT, et al. Poor outcome for neonatal-type nonketotic hyperglycinemia treated with high-dose sodium benzoate and dextromethorphan. J Child Neurol 2004;19:39-42. (Pubitemid 38351325)
18. Choi DW. Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci Lett 1985;58:293-7. (Pubitemid 15230671)
19. David HN, Haelewyn B, Rouillon C, Lecoq M, Chazalviel L, Apiou G, et al. Neuroprotective effects of xenon: a therapeutic window of opportunity in rats subjected to transient cerebral ischemia. FASEB J 2008;22:1275-86. (Pubitemid 351519980)
20. Dingley J, Tooley J, Porter H, Thoresen M. Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia. Stroke 2006;37:501-6. (Pubitemid 43732014)
21. Dobbing J, Sands J. Comparative aspects of the brain growth spurt. Early Hum Dev 1979;3:79-83. (Pubitemid 9141710)
22. Dribben WH, Creeley CE, Wang HH, Smith DJ, Farber NB, Olney JW. High dose magnesium sulfate exposure induces apoptotic cell death in the developing neonatal mouse brain. Neonatology 2009;96:23-32.
23. du Bois TM, Hsu CW, Li Y, Tan YY, Deng C, Huang XF. Altered dopamine receptor and dopamine transporter binding and tyrosine hydroxylase mRNA expression following perinatal NMDA receptor blockade. Neurochem Res 2008;33:1224-31.
24. Facchinetti F, Ciani E, Dall'Olio R, Virgili M, Contestabile A, Fonnum F. Structural, neurochemical and behavioural consequences of neonatal blockade of NMDA receptor through chronic treatment with CGP 39551 or MK-801. Brain Res Dev Brain Res 1993;74:219-24. (Pubitemid 23205440)
25. Follett PL, Rosenberg PA, Volpe JJ, Jensen FE. NBQX attenuates excitotoxic injury in developing white matter. J Neurosci 2000;20:9235-41. (Pubitemid 32042926)
26. Fontaine RH, Cases O, Lelievre V, Mesples B, Renauld JC, Loron G, et al. IL-9/IL-9 receptor signaling selectively protects cortical neurons against developmental apoptosis. Cell Death Differ 2008a;15:1542-52.
27. Fontaine RH, Olivier P, Massonneau V, Leroux P, Degos V, Lebon S, et al. Vulnerability of whitematter towards antenatalhypoxia is linked to a species-dependent regulation of glutamate receptor subunits. Proc Natl Acad Sci U S A 2008b;105:16779-84.
28. Fredriksson A, Archer T, Alm H, Gordh T, Eriksson P. Neurofunctional deficits and potentiated apoptosis by neonatal NMDA antagonist administration. Behav Brain Res 2004;153:367-76. (Pubitemid 38953110)
29. Fumagalli F, Pasini M, Frasca A, Drago F, Racagni G, Riva MA. Prenatal stress alters glutamatergic system responsiveness in adult rat prefrontal cortex. J Neurochem 2009;109:1733-44.
30. Grant KA, Valverius P, Hudspith M, Tabakoff B. Ethanol withdrawal seizures and the NMDA receptor complex. Eur J Pharmacol 1990;176:289-96. (Pubitemid 20076281)
31. Guo ZH, Li F, Wang WZ. The mechanisms of brain ischemic insult and potential protective interventions. Neurosci Bull 2009;25:139-52.
32. Hamosh A, Maher JF, Bellus GA, Rasmussen SA, Johnston MV. Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia. J Pediatr 1998;132:709-13. (Pubitemid 28194596)
33. Harris LW, Sharp T, Gartlon J, Jones DN, Harrison PJ. Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism. Eur J Neurosci 2003;18:1706-10. (Pubitemid 37215123)
34. Haugbol SR, Ebert B, Ulrichsen J. Upregulation of glutamate receptor subtypes during alcohol withdrawal in rats. Alcohol Alcohol 2005;40:89-95. (Pubitemid 40347334)
35. Hwang JY, Kim YH, Ahn YH, Wie MB, Koh JY. N-Methyl-D-aspartate receptor blockade induces neuronal apoptosis in cortical culture. Exp Neurol 1999;159:124-30.
36. Ikonomidou C. Triggers of apoptosis in the immature brain. Brain Dev 2009;31:488-92.
37. Ikonomidou C, Bittigau P, Ishimaru MJ, Wozniak DF, Koch C, Genz K, et al. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 2000;287:1056-60. (Pubitemid 30094364)
38. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999;283:70-4. (Pubitemid 29044848)
39. Ikonomidou C, Price MT, Mosinger JL, Frierdich G, Labruyere J, Salles KS, et al. Hypobaric-ischemic conditions produce glutamate-like cytopathology in infant rat brain. J Neurosci 1989;9:1693-700. (Pubitemid 19146264)
40. Insel TR, Miller LP, Gelhard RE. The ontogeny of excitatory amino acid receptors in rat forebrain - I. N-methyl-D-aspartate and quisqualate receptors. Neuroscience 1990;35:31-43. (Pubitemid 20113965)
41. Ishimaru MJ, Ikonomidou C, Tenkova TI, Der TC, Dikranian K, Sesma MA, et al. Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain. J Comp Neurol 1999;408:461-76. (Pubitemid 29211175)
42. Johnston MV, Hoon Jr AH. Possible mechanisms in infants for selective basal ganglia damage from asphyxia, kernicterus, or mitochondrial encephalopathies. J Child Neurol 2000;15:588-91.
43. Keller M, Griesmaier E, Auer M, Schlager G, Urbanek M, Simbruner G, et al. Dextromethorphan is protective against sensitized N-methyl-D-aspartate receptor-mediated excitotoxic brain damage in the developing mouse brain. Eur J Neurosci 2008;27:874-83. (Pubitemid 351365173)
44. Kew JN, Kemp JA. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology (Berl) 2005;179:4-29. (Pubitemid 40576690)
45. Khwaja O, Volpe JJ. Pathogenesis of cerebral white matter injury of prematurity. Arch Dis Child Fetal Neonatal Ed 2008;93:F153-61. (Pubitemid 352038509)
46. Kumari M, Ticku MK. Regulation of NMDA receptors by ethanol. Prog Drug Res 2000;54:152-89.
47. Leroux P, Hennebert C, Catteau J, Legros H, Hennebert O, Laudenbach V, et al. Neuroprotective effects vary across nonsteroidal antiinflammatory drugs in a mouse model of developing excitotoxic brain injury. Neuroscience 2010;167:716-23.
48. Lipton SA. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism. Curr Alzheimer Res 2005;2:155-65. (Pubitemid 40862876)
49. Liu Y, Qin L, Li G, Zhang W, An L, Liu B, et al. Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation. J Pharmacol Exp Ther 2003;305:212-8. (Pubitemid 36373853)
50. Lovinger DM. Interactions between ethanol and agents that act on the NMDA-type glutamate receptor. Alcohol Clin Exp Res 1996;20:187A-91A. (Pubitemid 26393988)
51. Low SJ, Roland CL. Review of NMDA antagonist-induced neurotoxicity and implications for clinical development. Int J Clin Pharmacol Ther 2004;42:1-14. (Pubitemid 38100854)
52. Lu H, Lim B, Poo MM. Cocaine exposure in utero alters synaptic plasticity in the medial prefrontal cortex of postnatal rats. J Neurosci 2009;29:12664-74.
53. Marret S, Gressens P, Gadisseux JF, Evrard P. Prevention by magnesium of excitotoxic neuronal death in the developing brain: an animal model for clinical intervention studies. Dev Med Child Neurol 1995a;37:473-84.
54. Marret S, Mukendi R, Gadisseux JF, Gressens P, Evrard P. Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions. J Neuropathol Exp Neurol 1995b;54:358-70.
55. Martel MA, Wyllie DJ, Hardingham GE. In developing hippocampal neurons, NR2B-containing N-methyl-D-aspartate receptors (NMDARs) can mediate signaling to neuronal survival and synaptic potentiation, as well as neuronal death. Neuroscience 2009;158:334-43.
56. McDonald JW, Silverstein FS, Cardona D, Hudson C, Chen R, Johnston MV. Systemic administration of MK-801 protects against N-methyl-D-aspartate- and quisqualate-mediated neurotoxicity in perinatal rats. Neuroscience 1990;36:589-99. (Pubitemid 20282174)
57. Mesples B, Fontaine RH, Lelievre V, Launay JM, Gressens P. Neuronal TGF-beta1 mediates IL-9/mast cell interaction and exacerbates excitotoxicity in newborn mice. Neurobiol Dis 2005;18:193-205. (Pubitemid 40092909)
58. Michaelis EK, Michaelis ML, Freed WJ, Foye J. Glutamate receptor changes in brain synaptic membranes during chronic alcohol intake. Alcohol Alcohol Suppl 1993;2:377-81.
59. Morrisett RA, Rezvani AH, Overstreet D, Janowsky DS, Wilson WA, Swartzwelder HS. MK-801 potently inhibits alcohol withdrawal seizures in rats. Eur J Pharmacol 1990;176:103-5. (Pubitemid 20035560)
60. Morrow CE, Culbertson JL, Accornero VH, Xue L, Anthony JC, Bandstra ES. Learning disabilities and intellectual functioning in school-aged children with prenatal cocaine exposure. Dev Neuropsychol 2006;30:905-31. (Pubitemid 44846220)
61. Noh MR, Kim SK, Sun W, Park SK, Choi HC, Lim JH, et al. Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats. Exp Neurol 2006;201:470-8. (Pubitemid 44344238)
62. Olney JW. New insights and new issues in developmental neurotoxicology. Neurotoxicology 2002;23:659-68. (Pubitemid 36004732)
63. Olney JW, Farber NB, Wozniak DF, Jevtovic-Todorovic V, Ikonomidou C. Environmental agents that have \the potential to trigger massive apoptotic neurodegeneration in the developing brain. Environ Health Perspect 2000;108(Suppl 3):383-8. (Pubitemid 30466160)
64. Olney JW, Sharpe LG, Feigin RD. Glutamate-induced brain damage in infant primates. J Neuropathol Exp Neurol 1972;31:464-88.
65. Patneau DK, Wright PW, Winters C, Mayer ML, Gallo V. Glial cells of the oligodendrocyte lineage express both kainate- and AMPA-preferring subtypes of glutamate receptor. Neuron 1994;12:357-71.
66. Qu Y, Vadivelu S, Choi L, Liu S, Lu A, Lewis B, et al. Neurons derived from embryonic stem (ES) cells resemble normal neurons in their vulnerability to excitotoxic death. Exp Neurol 2003;184:326-36. (Pubitemid 37444042)
67. Rangon CM, Fortes S, Lelievre V, Leroux P, Plaisant F, Joubert C, et al. Chronic mild stress during gestation worsens neonatal brain lesions in mice. J Neurosci 2007;27:7532-40. (Pubitemid 47066578)
68. Reyes E, Duran E, Switzer SH. Effects of in utero administration of alcohol on alcohol sensitivity in adult rats. Pharmacol Biochem Behav 1993;44:307-12.
69. Rice 3rd JE, Vannucci RC, Brierley JB. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 1981;9:131-41. (Pubitemid 11191192)
70. Ruiz A, Matute C, Alberdi E. Endoplasmic reticulum Ca(2+) release through ryanodine and IP(3) receptors contributes to neuronal excitotoxicity. Cell Calcium 2009;46:273-81.
71. Salter MG, Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 2005;438:1167-71. (Pubitemid 41831687)
72. Samudio-Ruiz SL, Allan AM, Sheema S, Caldwell KK. Hippocampal N-methyl-D-aspartate receptor subunit expression profiles in a mouse model of prenatal alcohol exposure. Alcohol Clin Exp Res 2010;34:342-53.
73. Samudio-Ruiz SL, Allan AM, Valenzuela CF, Perrone-Bizzozero NI, Caldwell KK. Prenatal ethanol exposure persistently impairs NMDA receptor-dependent activation of extracellular signal-regulated kinase in the mouse dentate gyrus. J Neurochem 2009;109:1311-23.
74. Sanna E, Serra M, Cossu A, Colombo G, Follesa P, Cuccheddu T, et al. Chronic ethanol intoxication induces differential effects on GABAA and NMDA receptor function in the rat brain. Alcohol Clin Exp Res 1993;17:115-23. (Pubitemid 23080977)
75. Sfaello I, Baud O, Arzimanoglou A, Gressens P. Topiramate prevents excitotoxic damage in the newborn rodent brain. Neurobiol Dis 2005;20:837-48. (Pubitemid 41619359)
76. Sircar R. Postnatal phencyclidine-induced deficit in adult water maze performance is associated with N-methyl-D-aspartate receptor upregulation. Int J Dev Neurosci 2003;21:159-67. (Pubitemid 36444541)
77. 4 administration after cerebral hypoxia-ischemia in newborn rats is related to the severity of brain damage. Reprod Sci 2007;14:667-77.
78. Stefani MR, Moghaddam B. Systemic and prefrontal cortical NMDA receptor blockade differentially affect discrimination learning and set-shift ability in rats. Behav Neurosci 2005;119:420-8. (Pubitemid 40547947)
79. Substance Abuse and Mental Health Administration. Results from the 2006 National Survey on Drug Use and Health: National Findings. 2010. Office of Applied Studies, NSDUH Series H-32, DHHS, Publication No.SMA 07-4293, Rockville, MD; 2007. Ref Type: Generic.
80. Swann JW, Pierson MG, Smith KL, Lee CL. Developmental neuroplasticity: roles in early life seizures and chronic epilepsy. Adv Neurol 1999;79:203-16.
81. Talos DM, Fishman RE, Park H, Folkerth RD, Follett PL, Volpe JJ, et al. Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. J Comp Neurol 2006;497:42-60. (Pubitemid 43844567)
82. Taylor DL, Pirianov G, Holland S, McGinnity CJ, Norman AL, Reali C, et al. Attenuation of proliferation in oligodendrocyte precursor cells by activated microglia. J Neurosci Res 2010;88:1632-44.
83. Tekkok SB, Goldberg MP. Ampa/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J Neurosci 2001;21:4237-48. (Pubitemid 32538549)
84. Turkyilmaz C, Turkyilmaz Z, Atalay Y, Soylemezoglu F, Celasun B. Magnesium pretreatment reduces neuronal apoptosis in newborn rats in hypoxia-ischemia. Brain Res 2002;955:133-7. (Pubitemid 35284843)
85. Volbracht C, van Beek J, Zhu C, Blomgren K, Leist M. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity. Eur J Neurosci 2006;23:2611-22. (Pubitemid 43801453)
86. Volpe JJ. Neurology of the Newborn. . Unit 15th edition. Saunders, Elsevier; 2010. p. 82. Ref Type: Generic.
87. Volpe JJ. Overview: normal and abnormal human brain development. Ment Retard Dev Disabil Res Rev 2000;6:1-5. (Pubitemid 30141806)
88. Wang C, McInnis J, Ross-Sanchez M, Shinnick-Gallagher P, Wiley JL, Johnson KM. Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia. Neuroscience 2001;107:535-50. (Pubitemid 33097492)
89. Wenzel A, Fritschy JM, Mohler H, Benke D. NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B, and NR2C subunit proteins. J Neurochem 1997;68:469-78. (Pubitemid 27044705)
90. Wenzel A, Scheurer L, Kunzi R, Fritschy JM, Mohler H, Benke D. Distribution of NMDA receptor subunit proteins NR2A, 2B, 2C and 2D in rat brain. Neuroreport 1995;7:45-8. (Pubitemid 26077198)
91. Wolf ME, Sun X, Mangiavacchi S, Chao SZ. Psychomotor stimulants and neuronal plasticity. Neuropharmacology 2004;47(Suppl 1):61-79. (Pubitemid 39298253)
92. Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR. Neurologic and developmental disability after extremely preterm birth. EPICure Study Group. N. Engl. J. Med. 2000;343:378-84. (Pubitemid 30626119)
93. Yoshioka A, Hardy M, Younkin DP, Grinspan JB, Stern JL, Pleasure D. Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors mediate excitotoxicity in the oligodendroglial lineage. J Neurochem 1995;64:2442-8.
94. Zhang LI, Poo MM. Electrical activity and development of neural circuits. Nat Neurosci 2001(4 Suppl):1207-14. (Pubitemid 33733110)
95. Zhang W, Wang T, Qin L, Gao HM, Wilson B, Ali SF, et al. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase. FASEB J 2004;18:589-91.